Novel Chinese patent medicine capable of benefiting heart and dispersing swelling

Abstract

A disclosed novel Chinese patent medicine capable of benefiting heart and dispersing swelling is prepared from the following raw materials in parts by weight: 20-30 parts of deer heart powder, 12-18 parts of cynanchumglaucescens, 12-25 parts of ganodermaapplanatum, 15-25 parts of radix scrophulariae, 15-25 parts of mongoliansnakegourd, 15-20 parts of calamus, 10-18 parts of fritillaria and 15-20 parts of cortex mori. Compared with conventional heart medicaments, the Chinese patent medicine of the invention has the advantages of relatively high cure rate, being capable of improving the function of the heart as a pump, improving myocardial vitality and the like; the Chinese patent medicine is capable of alleviating heart disease symptom in a short time, and the treatment effect is substantial; multiple traditional Chinese medicine components are used together and play the role of clearing fire and detoxifying, activating blood and transforming stasis, dissipating cold and relaxing muscles, unblocking meridian and vessels, dispelling dampness and stopping pain; the Chinese patent medicine is scientific in compatibility, rapid in effectiveness, and has the advantages of fast effectiveness, short treatment course and less cost on myocardial ischemia and angina pectoris caused by heart diseases.

Description

technical field [0001] The invention relates to a novel Chinese patent medicine for invigorating the heart and reducing swelling, which belongs to the field of traditional Chinese medicine. Background technique [0002] Heart disease is the general term for heart disease, including rheumatic heart disease, congenital heart disease, hypertensive heart disease, coronary heart disease, myocarditis and other heart diseases. Among them, rheumatic heart disease accounts for the first few in the number of hospitalized heart disease patients. Rheumatic fever is an acute or chronic systemic allergic connective tissue disease that mainly invades the heart and joints and is prone to relapse. Its clinical features are migratory polyarthritis, carditis, erythema annulare, chorea, etc. After acute or repeated attacks, obvious heart damage is often left over, especially the damage of heart valves, which eventually forms rheumatic heart valve disease, i.e. rheumatic heart disease. Rheumat...

AI Technical Summary

Problems solved by technology

At present, surgical treatment is mostly performed, including closed or direct-view mitral valve separation and mitral valve replacement. Although the curative effect is definite, thoracotomy is traumatic, and there is a certain risk and mortality, and the patient suffers a lot. The cost is high, so it is not easy for patients to accept